Dear Sir,

In December 2013, we reported a *Clostridium difficile* (CD) outbreak caused by the hyper-virulent ribotype 027 in the Provence-Alpes-Côte d'Azur (PACA) area, southeastern France [@bib1]. Sixty-one patients were hospitalized from March 2013 to April 2014 in the four university hospitals of Marseille (Timone, Conception, North and Sainte-Marguerite) for CD 027 infection, with a mortality of 43% [@bib2]. Following this outbreak, we developed an automated epidemiological surveillance system for CD cases.

*Cloatridium difficile* is associated with an elevated lethality worldwide [@bib2], [@bib3], [@bib4]. This lethality has gradually increased, exceeding that of many other bacterial species. In the present retrospective study, from January 2012 to December 2015, we compared the lethality rates of CD isolated in enterocolitis and the three most common bacterial pathogens isolated from any specimen (*Escherichia coli*, *Staphylococcus aureus* and *Pseudomonas aeruginosa*) in the university hospitals of Marseille, in the PACA area, France. The analysed data include the numbers of patients infected by each of the four above-mentioned bacterial species and the associated lethality for patients over 65 years old. The data at the Marseille and regional levels were obtained using our epidemiological surveillance system whereas national data were obtained by the medical information service in Timone hospital (National Data obtained by *Convention de droit d'usage des données* PMSI, N°d'agrément 2015-111111-88-46). Duplicates were removed. For a given patient, only the first infection caused by a given microorganism was registered. We calculated the annual lethality rates (for the years 2012 to 2015) by dividing the number of deaths by the number of patients affected by the respective bacterial species by each year. All data collection and descriptive epidemiological analyses were performed in [Excel]{.smallcaps}.

Within Marseille university hospitals, we observed a stable lethality rate of *E. coli* urinary-tract infections between 2012 and 2015 (3.6%--5.6%, [Table 1](#tbl1){ref-type="table"}). For *E. coli* bacteraemia, the lethality increased from 2012 to 2014 (11.8%--18.3%, [Table 1](#tbl1){ref-type="table"}) and decreased in 2015 (10.7%). For *S. aureus* bacteraemia, the lethality decreased constantly from 22.9% in 2012 to 19.1% in 2014 ([Table 1](#tbl1){ref-type="table"}) then increased in 2015 (20.3%). For *P. aeruginosa* bacteraemia the lethality increased from 2012 (28.6%) to 2013 (31.7%), then decreased in 2014 (23.1%) and increased in 2015 (30.4%; [Table 1](#tbl1){ref-type="table"}). The CD lethality rate was lower in 2012 (10.6%) than in other years and reached a peak of 18.3% in 2013 (1.7-fold increase) and then decreased in 2014 (17.9%) and 2015 (12.4%).

At the PACA level, in 2012, 2013 and 2014, the lethality rate of CD infections was also lower than those of other pathogens ([Table 1](#tbl1){ref-type="table"}). At the country level, the highest lethality rate in 2012 and 2013 was that of *P. aeruginosa*, which was slightly higher than that of *C. difficile*.

When considering the evolution of lethality rates over time ([Table 1](#tbl1){ref-type="table"}), we observed that CD-related mortality had the greatest variation among bacterial pathogens in Marseille and PACA, which may be explained by the 2013--2014 CD 027 outbreak [@bib2]. We also observed a great reduction in CD-related lethality in 2015, although non-significant (two-sided Pearson's chi-square test, p 0.09). This reduction followed the implementation of systematic faecal microbiota transplantation for patients hospitalized in Marseille university hospitals with CD 027 infections [@bib2].

Together, these results confirmed that CD is a major life-threatening bacterial pathogen, especially for the elderly, like *P. aeruginosa*. This confirms what was previously observed in our region [@bib1], [@bib5] and also in northern France and other countries [@bib6], [@bib7]. The rapid decrease in the lethality of CD infections in Marseille university hospitals (18.3% to 12.4%) and the PACA region can be explained by the introduction of new treatment for all patients in PACA, the faecal microbiota transplantation [@bib5].

Our study demonstrated that the CD-related lethality was similar in Marseille university hospitals and at the regional and national levels and was lower than those caused by *P. aeruginosa* or *S. aureus*. CD remains a major public health concern. Moreover, our results should encourage hospitals to extensively survey CD infections by the implementation of automatic monitoring systems, and also by developing rapid screening procedures to identify and isolate infected patients and healthy carriers upon hospitalization.

###### 

Number of deaths and lethality rate of infection caused by *Clostridium difficile* and the three most common bacterial pathogens in Marseille university Hospitals, Provence-Alpes-Côte d'Azur region and France from January 2012 to December 2015

Table 1

  Bacterial species                                    Marseille University Hospitals   PACA Region   France                                                   
  ---------------------------------------------------- -------------------------------- ------------- -------- --------- -------- ------ ----------- --------- ------
  2012                                                                                                                                                         
  Global mortality[b](#tbl1fnb){ref-type="table-fn"}   30 890                           1581          5.1      339 182   19 037   5.6    3 502 943   215 945   6.2
  *Clostridium difficile*                              47                               5             10.6     566       86       15.2   7500        1288      17.2
  *Escherichia coli* bacteraemia                       136                              16            11.8     1146      298      26.0   10 752      2575      23.9
  *Escherichia coli* UTI                               380                              21            5.5      8 562     688      8.0    97 357      5891      6.1
  *Staphylococcus aureus* bacteraemia                  105                              24            22.9     660       238      36.1   8131        2539      31.2
  *Pseudomonas aeruginosa* bacteraemia                 28                               8             28.6     324       131      40.4   3028        1176      38.8
  2013                                                                                                                                                         
  Global mortality[b](#tbl1fnb){ref-type="table-fn"}   31 723                           1583          5.0      347 520   19 220   5.5    3 588 311   215 303   6.0
  *Clostridium difficile*                              142\*                            26\*          18.3     710       142      20.0   8461        1511      17.9
  *Escherichia coli* bacteraemia                       133                              22            16.5     1201      313      26.1   11 574      2923      25.3
  *Escherichia coli* UTI                               478                              17            3.6      9023      642      7.1    103 746     6549      6.3
  *Staphylococcus aureus* bacteraemia                  104                              21            20.2     687       222      32.3   7988        2669      33.4
  *Pseudomonas aeruginosa* bacteraemia                 41                               13            31.7     333       122      36.6   3155        1168      37.0
  2014                                                                                                                                                         
  Global mortality[b](#tbl1fnb){ref-type="table-fn"}   32 335                           1559          4.8      356 108   19 427   5.5    3 695 116   216 734   5.9
  *Clostridium difficile*                              148                              27            18.2     914       175      19.1   8883        1580      17.8
  *Escherichia coli* bacteraemia                       197                              36            18.3     1365      310      22.7   13 069      3095      23.7
  *Escherichia coli* UTI                               534                              29            5.4      9679      733      7.6    110 565     6939      6.3
  *Staphylococcus aureus* bacteraemia                  173                              33            19.1     771       269      34.9   8350        2774      33.2
  *Pseudomonas aeruginosa* bacteraemia                 52                               12            23.1     404       126      31.2   3325        1158      34.8
  2015                                                                                                                                                         
  Global mortality[b](#tbl1fnb){ref-type="table-fn"}   32 555                           1645          5.1      N/A       N/A      N/A    3 836 118   229 608   6.0
  *Clostridium difficile*                              153\*                            19\*          12.4     N/A       N/A      N/A    11 336      1972      17.4
  *Escherichia coli* bacteraemia                       242                              26            10.7     N/A       N/A      N/A    21 901      4152      19.0
  *Escherichia coli* UTI                               1 111                            62            5.6      N/A       N/A      N/A    114 962     7507      6.5
  *Staphylococcus aureus* bacteraemia                  143                              29            20.3     N/A       N/A      N/A    11 481      3608      31.4
  *Pseudomonas aeruginosa* bacteraemia                 56                               17            30.4     N/A       N/A      N/A    4301        1483      34.5

UTI, urinary tract infection.

\*p 0.09, not significant.

National Data obtained by: *Convention de droit d'usage des données* PMSI, N°d'agrément 2015-111111-88-46.

Includes all causes of death, infectious or not.
